nodes	percent_of_prediction	percent_of_DWPC	metapath
Bumetanide—SLC10A1—Liothyronine—hypothyroidism	0.242	0.294	CbGbCtD
Bumetanide—SLC10A1—Liotrix—hypothyroidism	0.236	0.286	CbGbCtD
Bumetanide—SLCO1A2—Levothyroxine—hypothyroidism	0.0736	0.0894	CbGbCtD
Bumetanide—SLCO1A2—Liothyronine—hypothyroidism	0.0736	0.0894	CbGbCtD
Bumetanide—SLCO1A2—Liotrix—hypothyroidism	0.0719	0.0873	CbGbCtD
Bumetanide—SLC22A8—Liothyronine—hypothyroidism	0.0641	0.0779	CbGbCtD
Bumetanide—SLC22A8—Liotrix—hypothyroidism	0.0626	0.076	CbGbCtD
Bumetanide—SLC12A5—nerve—hypothyroidism	0.00716	0.0827	CbGeAlD
Bumetanide—SLC12A1—urine—hypothyroidism	0.00498	0.0576	CbGeAlD
Bumetanide—SLC22A8—urine—hypothyroidism	0.00289	0.0334	CbGeAlD
Bumetanide—SLC12A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A4—hypothyroidism	0.00246	0.0497	CbGpPWpGaD
Bumetanide—SLC12A4—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A4—hypothyroidism	0.00246	0.0497	CbGpPWpGaD
Bumetanide—SLC12A5—pituitary gland—hypothyroidism	0.00222	0.0256	CbGeAlD
Bumetanide—SLC12A4—heart—hypothyroidism	0.00221	0.0255	CbGeAlD
Bumetanide—SLC12A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A4—hypothyroidism	0.00209	0.0423	CbGpPWpGaD
Bumetanide—SLC12A4—cardiovascular system—hypothyroidism	0.00208	0.0241	CbGeAlD
Bumetanide—SLC12A4—gonad—hypothyroidism	0.00189	0.0218	CbGeAlD
Bumetanide—CA4—nerve—hypothyroidism	0.00185	0.0214	CbGeAlD
Bumetanide—Hypotension—Liothyronine—hypothyroidism	0.0017	0.0416	CcSEcCtD
Bumetanide—Dehydration—Levothyroxine—hypothyroidism	0.00169	0.0414	CcSEcCtD
Bumetanide—Dehydration—Dextrothyroxine—hypothyroidism	0.00169	0.0414	CcSEcCtD
Bumetanide—SLC12A4—adrenal gland—hypothyroidism	0.00165	0.019	CbGeAlD
Bumetanide—SLC12A5—testis—hypothyroidism	0.00164	0.0189	CbGeAlD
Bumetanide—SLC12A4—thyroid gland—hypothyroidism	0.00159	0.0184	CbGeAlD
Bumetanide—SLC12A2—adrenal cortex—hypothyroidism	0.00157	0.0182	CbGeAlD
Bumetanide—SLC12A4—female gonad—hypothyroidism	0.00154	0.0177	CbGeAlD
Bumetanide—SLC12A2—heart—hypothyroidism	0.00152	0.0176	CbGeAlD
Bumetanide—SLC12A5—cerebellum—hypothyroidism	0.00151	0.0175	CbGeAlD
Bumetanide—CA5A—liver—hypothyroidism	0.0015	0.0173	CbGeAlD
Bumetanide—SLC12A2—cardiovascular system—hypothyroidism	0.00144	0.0166	CbGeAlD
Bumetanide—CA14—heart—hypothyroidism	0.00142	0.0164	CbGeAlD
Bumetanide—SLC12A4—testis—hypothyroidism	0.00136	0.0157	CbGeAlD
Bumetanide—Sweating—Dextrothyroxine—hypothyroidism	0.00134	0.0329	CcSEcCtD
Bumetanide—Sweating—Levothyroxine—hypothyroidism	0.00134	0.0329	CcSEcCtD
Bumetanide—SLC12A5—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00133	0.0268	CbGpPWpGaD
Bumetanide—SLC12A4—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00133	0.0268	CbGpPWpGaD
Bumetanide—SLC12A2—gonad—hypothyroidism	0.0013	0.0151	CbGeAlD
Bumetanide—CFTR—blood—hypothyroidism	0.00129	0.0149	CbGeAlD
Bumetanide—SLC12A4—liver—hypothyroidism	0.00129	0.0149	CbGeAlD
Bumetanide—SLC12A2—pituitary gland—hypothyroidism	0.00127	0.0147	CbGeAlD
Bumetanide—SLC12A4—cerebellum—hypothyroidism	0.00126	0.0145	CbGeAlD
Bumetanide—Blood creatinine increased—Liotrix—hypothyroidism	0.00125	0.0306	CcSEcCtD
Bumetanide—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A4—hypothyroidism	0.00124	0.0251	CbGpPWpGaD
Bumetanide—Dehydration—Liotrix—hypothyroidism	0.00124	0.0304	CcSEcCtD
Bumetanide—SLC10A1—gonad—hypothyroidism	0.00123	0.0142	CbGeAlD
Bumetanide—Hypokalaemia—Liotrix—hypothyroidism	0.00121	0.0298	CcSEcCtD
Bumetanide—CFTR—female gonad—hypothyroidism	0.00121	0.0139	CbGeAlD
Bumetanide—SLC12A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—hypothyroidism	0.00119	0.024	CbGpPWpGaD
Bumetanide—SLC12A4—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—hypothyroidism	0.00119	0.024	CbGpPWpGaD
Bumetanide—SLC12A2—adrenal gland—hypothyroidism	0.00114	0.0131	CbGeAlD
Bumetanide—SLC12A2—blood—hypothyroidism	0.00114	0.0131	CbGeAlD
Bumetanide—SLC12A2—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00113	0.0228	CbGpPWpGaD
Bumetanide—SLC12A5—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.0011	0.0222	CbGpPWpGaD
Bumetanide—SLC12A4—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.0011	0.0222	CbGpPWpGaD
Bumetanide—SLC12A2—thyroid gland—hypothyroidism	0.0011	0.0127	CbGeAlD
Bumetanide—SLCO1A2—Transport of organic anions—AVP—hypothyroidism	0.00107	0.0216	CbGpPWpGaD
Bumetanide—CFTR—testis—hypothyroidism	0.00107	0.0124	CbGeAlD
Bumetanide—CA14—adrenal gland—hypothyroidism	0.00106	0.0123	CbGeAlD
Bumetanide—SLC12A2—female gonad—hypothyroidism	0.00106	0.0122	CbGeAlD
Bumetanide—CFTR—liver—hypothyroidism	0.00101	0.0117	CbGeAlD
Bumetanide—Renal failure—Liotrix—hypothyroidism	0.00101	0.0248	CcSEcCtD
Bumetanide—SLC12A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—hypothyroidism	0.00101	0.0204	CbGpPWpGaD
Bumetanide—CA5B—heart—hypothyroidism	0.000995	0.0115	CbGeAlD
Bumetanide—Sweating—Liotrix—hypothyroidism	0.000985	0.0242	CcSEcCtD
Bumetanide—CA7—cerebellum—hypothyroidism	0.000973	0.0112	CbGeAlD
Bumetanide—SLC12A1—blood—hypothyroidism	0.000953	0.011	CbGeAlD
Bumetanide—SLC12A2—testis—hypothyroidism	0.00094	0.0109	CbGeAlD
Bumetanide—CA5B—cardiovascular system—hypothyroidism	0.000939	0.0108	CbGeAlD
Bumetanide—SLC12A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000934	0.0189	CbGpPWpGaD
Bumetanide—Arthralgia—Levothyroxine—hypothyroidism	0.000929	0.0228	CcSEcCtD
Bumetanide—Arthralgia—Dextrothyroxine—hypothyroidism	0.000929	0.0228	CcSEcCtD
Bumetanide—CA9—testis—hypothyroidism	0.000925	0.0107	CbGeAlD
Bumetanide—SLC12A2—liver—hypothyroidism	0.000888	0.0103	CbGeAlD
Bumetanide—SLC10A1—testis—hypothyroidism	0.000888	0.0103	CbGeAlD
Bumetanide—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.000881	0.0178	CbGpPWpGaD
Bumetanide—SLC12A2—cerebellum—hypothyroidism	0.000868	0.01	CbGeAlD
Bumetanide—Hyperhidrosis—Levothyroxine—hypothyroidism	0.000861	0.0211	CcSEcCtD
Bumetanide—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.000861	0.0211	CcSEcCtD
Bumetanide—CA9—cerebellum—hypothyroidism	0.000855	0.00987	CbGeAlD
Bumetanide—CA5B—gonad—hypothyroidism	0.000852	0.00984	CbGeAlD
Bumetanide—SLC10A1—liver—hypothyroidism	0.000839	0.0097	CbGeAlD
Bumetanide—CA14—liver—hypothyroidism	0.00083	0.00959	CbGeAlD
Bumetanide—CA14—cerebellum—hypothyroidism	0.000811	0.00936	CbGeAlD
Bumetanide—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.000799	0.0162	CbGpPWpGaD
Bumetanide—SLC22A7—testis—hypothyroidism	0.000791	0.00914	CbGeAlD
Bumetanide—SLC12A1—testis—hypothyroidism	0.000788	0.0091	CbGeAlD
Bumetanide—Fatigue—Dextrothyroxine—hypothyroidism	0.000768	0.0188	CcSEcCtD
Bumetanide—Fatigue—Levothyroxine—hypothyroidism	0.000768	0.0188	CcSEcCtD
Bumetanide—SLC22A11—liver—hypothyroidism	0.000767	0.00886	CbGeAlD
Bumetanide—SLC22A7—liver—hypothyroidism	0.000748	0.00864	CbGeAlD
Bumetanide—CA5B—adrenal gland—hypothyroidism	0.000742	0.00858	CbGeAlD
Bumetanide—CA5B—blood—hypothyroidism	0.000742	0.00858	CbGeAlD
Bumetanide—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.000728	0.0179	CcSEcCtD
Bumetanide—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.000728	0.0179	CcSEcCtD
Bumetanide—CA5B—thyroid gland—hypothyroidism	0.000716	0.00828	CbGeAlD
Bumetanide—Urticaria—Levothyroxine—hypothyroidism	0.000708	0.0174	CcSEcCtD
Bumetanide—Urticaria—Dextrothyroxine—hypothyroidism	0.000708	0.0174	CcSEcCtD
Bumetanide—Abdominal pain—Dextrothyroxine—hypothyroidism	0.000704	0.0173	CcSEcCtD
Bumetanide—Abdominal pain—Levothyroxine—hypothyroidism	0.000704	0.0173	CcSEcCtD
Bumetanide—CA4—heart—hypothyroidism	0.000687	0.00793	CbGeAlD
Bumetanide—Chest pain—Liotrix—hypothyroidism	0.000684	0.0168	CcSEcCtD
Bumetanide—Arthralgia—Liotrix—hypothyroidism	0.000684	0.0168	CcSEcCtD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000674	0.0136	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000674	0.0136	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000674	0.0136	CbGpPWpGaD
Bumetanide—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.000672	0.0136	CbGpPWpGaD
Bumetanide—SLC12A1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000671	0.0136	CbGpPWpGaD
Bumetanide—CA4—cardiovascular system—hypothyroidism	0.000648	0.00748	CbGeAlD
Bumetanide—Asthenia—Dextrothyroxine—hypothyroidism	0.000639	0.0157	CcSEcCtD
Bumetanide—Asthenia—Levothyroxine—hypothyroidism	0.000639	0.0157	CcSEcCtD
Bumetanide—Hyperhidrosis—Liotrix—hypothyroidism	0.000634	0.0155	CcSEcCtD
Bumetanide—Pruritus—Levothyroxine—hypothyroidism	0.00063	0.0155	CcSEcCtD
Bumetanide—Pruritus—Dextrothyroxine—hypothyroidism	0.00063	0.0155	CcSEcCtD
Bumetanide—CA5B—testis—hypothyroidism	0.000614	0.00709	CbGeAlD
Bumetanide—Hypotension—Liotrix—hypothyroidism	0.000612	0.015	CcSEcCtD
Bumetanide—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00061	0.015	CcSEcCtD
Bumetanide—Diarrhoea—Levothyroxine—hypothyroidism	0.00061	0.015	CcSEcCtD
Bumetanide—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—hypothyroidism	0.0006	0.0121	CbGpPWpGaD
Bumetanide—CA4—pituitary gland—hypothyroidism	0.000574	0.00663	CbGeAlD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000573	0.0116	CbGpPWpGaD
Bumetanide—Vomiting—Dextrothyroxine—hypothyroidism	0.000566	0.0139	CcSEcCtD
Bumetanide—Vomiting—Levothyroxine—hypothyroidism	0.000566	0.0139	CcSEcCtD
Bumetanide—Fatigue—Liotrix—hypothyroidism	0.000565	0.0139	CcSEcCtD
Bumetanide—Rash—Levothyroxine—hypothyroidism	0.000562	0.0138	CcSEcCtD
Bumetanide—Rash—Dextrothyroxine—hypothyroidism	0.000562	0.0138	CcSEcCtD
Bumetanide—Dermatitis—Dextrothyroxine—hypothyroidism	0.000561	0.0138	CcSEcCtD
Bumetanide—Dermatitis—Levothyroxine—hypothyroidism	0.000561	0.0138	CcSEcCtD
Bumetanide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00056	0.0113	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000558	0.0113	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000558	0.0113	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000558	0.0113	CbGpPWpGaD
Bumetanide—Headache—Dextrothyroxine—hypothyroidism	0.000558	0.0137	CcSEcCtD
Bumetanide—Headache—Levothyroxine—hypothyroidism	0.000558	0.0137	CcSEcCtD
Bumetanide—SLC12A1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000556	0.0112	CbGpPWpGaD
Bumetanide—SLC22A8—blood—hypothyroidism	0.000553	0.00639	CbGeAlD
Bumetanide—Gastrointestinal pain—Liotrix—hypothyroidism	0.000536	0.0131	CcSEcCtD
Bumetanide—SLC12A4—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.00053	0.0107	CbGpPWpGaD
Bumetanide—SLC12A5—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.00053	0.0107	CbGpPWpGaD
Bumetanide—Nausea—Levothyroxine—hypothyroidism	0.000529	0.013	CcSEcCtD
Bumetanide—Nausea—Dextrothyroxine—hypothyroidism	0.000529	0.013	CcSEcCtD
Bumetanide—Urticaria—Liotrix—hypothyroidism	0.000521	0.0128	CcSEcCtD
Bumetanide—Abdominal pain—Liotrix—hypothyroidism	0.000518	0.0127	CcSEcCtD
Bumetanide—CA4—adrenal gland—hypothyroidism	0.000512	0.00592	CbGeAlD
Bumetanide—CA4—blood—hypothyroidism	0.000512	0.00592	CbGeAlD
Bumetanide—CA4—thyroid gland—hypothyroidism	0.000495	0.00571	CbGeAlD
Bumetanide—SLCO1A2—testis—hypothyroidism	0.000479	0.00553	CbGeAlD
Bumetanide—CA4—female gonad—hypothyroidism	0.000478	0.00552	CbGeAlD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000475	0.0096	CbGpPWpGaD
Bumetanide—Asthenia—Liotrix—hypothyroidism	0.00047	0.0115	CcSEcCtD
Bumetanide—Pruritus—Liotrix—hypothyroidism	0.000464	0.0114	CcSEcCtD
Bumetanide—SLCO1A2—liver—hypothyroidism	0.000453	0.00523	CbGeAlD
Bumetanide—SLC12A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000451	0.00911	CbGpPWpGaD
Bumetanide—Diarrhoea—Liotrix—hypothyroidism	0.000448	0.011	CcSEcCtD
Bumetanide—SLCO1A2—cerebellum—hypothyroidism	0.000442	0.00511	CbGeAlD
Bumetanide—PTGS2—adrenal cortex—hypothyroidism	0.000435	0.00502	CbGeAlD
Bumetanide—Dizziness—Liotrix—hypothyroidism	0.000433	0.0106	CcSEcCtD
Bumetanide—CA4—testis—hypothyroidism	0.000424	0.0049	CbGeAlD
Bumetanide—PTGS2—heart—hypothyroidism	0.00042	0.00486	CbGeAlD
Bumetanide—SLC12A5—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000417	0.00844	CbGpPWpGaD
Bumetanide—SLC12A4—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000417	0.00844	CbGpPWpGaD
Bumetanide—Vomiting—Liotrix—hypothyroidism	0.000417	0.0102	CcSEcCtD
Bumetanide—Rash—Liotrix—hypothyroidism	0.000413	0.0101	CcSEcCtD
Bumetanide—Dermatitis—Liotrix—hypothyroidism	0.000413	0.0101	CcSEcCtD
Bumetanide—Headache—Liotrix—hypothyroidism	0.000411	0.0101	CcSEcCtD
Bumetanide—SLC22A11—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.0004	0.00809	CbGpPWpGaD
Bumetanide—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.000397	0.00803	CbGpPWpGaD
Bumetanide—PTGS2—cardiovascular system—hypothyroidism	0.000397	0.00458	CbGeAlD
Bumetanide—CA4—cerebellum—hypothyroidism	0.000391	0.00452	CbGeAlD
Bumetanide—Nausea—Liotrix—hypothyroidism	0.000389	0.00955	CcSEcCtD
Bumetanide—SLC22A7—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000363	0.00734	CbGpPWpGaD
Bumetanide—SLC12A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000355	0.00718	CbGpPWpGaD
Bumetanide—PTGS2—pituitary gland—hypothyroidism	0.000351	0.00406	CbGeAlD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000341	0.00689	CbGpPWpGaD
Bumetanide—SLC22A11—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000332	0.0067	CbGpPWpGaD
Bumetanide—PTGS2—Prostaglandin Synthesis and Regulation—PRL—hypothyroidism	0.000325	0.00657	CbGpPWpGaD
Bumetanide—PTGS2—adrenal gland—hypothyroidism	0.000314	0.00362	CbGeAlD
Bumetanide—PTGS2—blood—hypothyroidism	0.000314	0.00362	CbGeAlD
Bumetanide—SLC22A8—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000305	0.00617	CbGpPWpGaD
Bumetanide—SLC22A7—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000301	0.00608	CbGpPWpGaD
Bumetanide—PTGS2—female gonad—hypothyroidism	0.000293	0.00338	CbGeAlD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000282	0.00571	CbGpPWpGaD
Bumetanide—SLCO1A2—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000271	0.00548	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000269	0.00545	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000269	0.00545	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000269	0.00545	CbGpPWpGaD
Bumetanide—CA14—Metabolism—IYD—hypothyroidism	0.000268	0.00543	CbGpPWpGaD
Bumetanide—SLC12A1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000268	0.00542	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—IYD—hypothyroidism	0.000262	0.00529	CbGpPWpGaD
Bumetanide—SLC22A6—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000255	0.00515	CbGpPWpGaD
Bumetanide—SLC22A8—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000253	0.00511	CbGpPWpGaD
Bumetanide—PTGS2—liver—hypothyroidism	0.000245	0.00283	CbGeAlD
Bumetanide—CA5B—Metabolism—IYD—hypothyroidism	0.000244	0.00494	CbGpPWpGaD
Bumetanide—CA7—Metabolism—IYD—hypothyroidism	0.000244	0.00494	CbGpPWpGaD
Bumetanide—PTGS2—cerebellum—hypothyroidism	0.00024	0.00277	CbGeAlD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000229	0.00463	CbGpPWpGaD
Bumetanide—CA14—Metabolism—ATP5O—hypothyroidism	0.000228	0.00461	CbGpPWpGaD
Bumetanide—CA12—Metabolism—IYD—hypothyroidism	0.000226	0.00457	CbGpPWpGaD
Bumetanide—SLCO1A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000225	0.00454	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—ATP5O—hypothyroidism	0.000222	0.0045	CbGpPWpGaD
Bumetanide—CA14—Metabolism—TPO—hypothyroidism	0.000215	0.00434	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000212	0.00429	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000212	0.00429	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000212	0.00429	CbGpPWpGaD
Bumetanide—SLC22A6—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000211	0.00427	CbGpPWpGaD
Bumetanide—SLC12A1—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000211	0.00427	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—TPO—hypothyroidism	0.000209	0.00423	CbGpPWpGaD
Bumetanide—CA7—Metabolism—ATP5O—hypothyroidism	0.000208	0.0042	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—ATP5O—hypothyroidism	0.000208	0.0042	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000203	0.00411	CbGpPWpGaD
Bumetanide—CA7—Metabolism—TPO—hypothyroidism	0.000195	0.00395	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—TPO—hypothyroidism	0.000195	0.00395	CbGpPWpGaD
Bumetanide—CA12—Metabolism—ATP5O—hypothyroidism	0.000192	0.00389	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—IYD—hypothyroidism	0.000189	0.00382	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000184	0.00373	CbGpPWpGaD
Bumetanide—CA12—Metabolism—TPO—hypothyroidism	0.000181	0.00366	CbGpPWpGaD
Bumetanide—CA4—Metabolism—IYD—hypothyroidism	0.00018	0.00365	CbGpPWpGaD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.00018	0.00365	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000168	0.00341	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—ATP5O—hypothyroidism	0.000161	0.00325	CbGpPWpGaD
Bumetanide—SLC22A11—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.00016	0.00323	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000155	0.00314	CbGpPWpGaD
Bumetanide—CA4—Metabolism—ATP5O—hypothyroidism	0.000153	0.0031	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000153	0.00309	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—TPO—hypothyroidism	0.000151	0.00306	CbGpPWpGaD
Bumetanide—CA9—Metabolism—IYD—hypothyroidism	0.000146	0.00295	CbGpPWpGaD
Bumetanide—SLC22A7—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000145	0.00293	CbGpPWpGaD
Bumetanide—CA4—Metabolism—TPO—hypothyroidism	0.000144	0.00292	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.00014	0.00283	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000138	0.00278	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000136	0.00275	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000129	0.00262	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000128	0.0026	CbGpPWpGaD
Bumetanide—SLC22A11—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000126	0.00255	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ATP5O—hypothyroidism	0.000124	0.00251	CbGpPWpGaD
Bumetanide—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000122	0.00247	CbGpPWpGaD
Bumetanide—CA9—Metabolism—TPO—hypothyroidism	0.000117	0.00236	CbGpPWpGaD
Bumetanide—SLC22A7—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000114	0.00231	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000114	0.00231	CbGpPWpGaD
Bumetanide—SLCO1A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000108	0.00219	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000107	0.00217	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000107	0.00217	CbGpPWpGaD
Bumetanide—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000102	0.00206	CbGpPWpGaD
Bumetanide—CA14—Metabolism—TSHB—hypothyroidism	9.93e-05	0.00201	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—TSHB—hypothyroidism	9.68e-05	0.00196	CbGpPWpGaD
Bumetanide—SLC22A8—SLC-mediated transmembrane transport—AVP—hypothyroidism	9.6e-05	0.00194	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—IYD—hypothyroidism	9.3e-05	0.00188	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—TSHB—hypothyroidism	9.04e-05	0.00183	CbGpPWpGaD
Bumetanide—CA7—Metabolism—TSHB—hypothyroidism	9.04e-05	0.00183	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PIK3C2A—hypothyroidism	8.85e-05	0.00179	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PIK3C2A—hypothyroidism	8.63e-05	0.00174	CbGpPWpGaD
Bumetanide—SLCO1A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	8.53e-05	0.00172	CbGpPWpGaD
Bumetanide—CA12—Metabolism—TSHB—hypothyroidism	8.37e-05	0.00169	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	8.13e-05	0.00164	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PIK3C2A—hypothyroidism	8.05e-05	0.00163	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PIK3C2A—hypothyroidism	8.05e-05	0.00163	CbGpPWpGaD
Bumetanide—SLC22A6—SLC-mediated transmembrane transport—AVP—hypothyroidism	8.01e-05	0.00162	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ATP5O—hypothyroidism	7.91e-05	0.0016	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PIK3C2A—hypothyroidism	7.46e-05	0.00151	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—TPO—hypothyroidism	7.44e-05	0.0015	CbGpPWpGaD
Bumetanide—CA14—Metabolism—SLC5A5—hypothyroidism	7.44e-05	0.0015	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	7.37e-05	0.00149	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—SLC5A5—hypothyroidism	7.25e-05	0.00147	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—TSHB—hypothyroidism	7e-05	0.00142	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	6.89e-05	0.00139	CbGpPWpGaD
Bumetanide—CA7—Metabolism—SLC5A5—hypothyroidism	6.77e-05	0.00137	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—SLC5A5—hypothyroidism	6.77e-05	0.00137	CbGpPWpGaD
Bumetanide—CA4—Metabolism—TSHB—hypothyroidism	6.68e-05	0.00135	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—AVP—hypothyroidism	6.4e-05	0.00129	CbGpPWpGaD
Bumetanide—CA12—Metabolism—SLC5A5—hypothyroidism	6.27e-05	0.00127	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PIK3C2A—hypothyroidism	6.24e-05	0.00126	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	6.2e-05	0.00125	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	6.15e-05	0.00124	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PIK3C2A—hypothyroidism	5.95e-05	0.0012	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—AVP—hypothyroidism	5.81e-05	0.00117	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—IYD—hypothyroidism	5.62e-05	0.00114	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.5e-05	0.00111	CbGpPWpGaD
Bumetanide—CA9—Metabolism—TSHB—hypothyroidism	5.39e-05	0.00109	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—SLC5A5—hypothyroidism	5.24e-05	0.00106	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.17e-05	0.00105	CbGpPWpGaD
Bumetanide—CA4—Metabolism—SLC5A5—hypothyroidism	5e-05	0.00101	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—AVP—hypothyroidism	4.88e-05	0.000987	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PIK3C2A—hypothyroidism	4.81e-05	0.000972	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ATP5O—hypothyroidism	4.78e-05	0.000966	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—TPO—hypothyroidism	4.49e-05	0.000908	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—AVP—hypothyroidism	4.33e-05	0.000876	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	4.21e-05	0.000852	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	4.16e-05	0.000842	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—AVP—hypothyroidism	4.07e-05	0.000824	CbGpPWpGaD
Bumetanide—CA9—Metabolism—SLC5A5—hypothyroidism	4.04e-05	0.000817	CbGpPWpGaD
Bumetanide—CA14—Metabolism—POMC—hypothyroidism	3.89e-05	0.000787	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—POMC—hypothyroidism	3.79e-05	0.000767	CbGpPWpGaD
Bumetanide—CA7—Metabolism—POMC—hypothyroidism	3.54e-05	0.000716	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—POMC—hypothyroidism	3.54e-05	0.000716	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—TSHB—hypothyroidism	3.44e-05	0.000696	CbGpPWpGaD
Bumetanide—CA12—Metabolism—POMC—hypothyroidism	3.28e-05	0.000663	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PIK3C2A—hypothyroidism	3.07e-05	0.000621	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.03e-05	0.000612	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—POMC—hypothyroidism	2.74e-05	0.000554	CbGpPWpGaD
Bumetanide—CA4—Metabolism—POMC—hypothyroidism	2.61e-05	0.000529	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—SLC5A5—hypothyroidism	2.58e-05	0.000521	CbGpPWpGaD
Bumetanide—CA9—Metabolism—POMC—hypothyroidism	2.11e-05	0.000427	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—TSHB—hypothyroidism	2.08e-05	0.00042	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PIK3C2A—hypothyroidism	1.85e-05	0.000375	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.83e-05	0.00037	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PRL—hypothyroidism	1.64e-05	0.000332	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SLC5A5—hypothyroidism	1.56e-05	0.000315	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—POMC—hypothyroidism	1.35e-05	0.000273	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—POMC—hypothyroidism	8.14e-06	0.000165	CbGpPWpGaD
